Condition: Breast Cancer Screening · Sponsor: University of Pennsylvania
This is an observational study to evaluate the MAMMOMAT B.brilliant system. All diagnostic decisions are made by the treating radiologist based upon standard of care clinical imaging acquired on FDA approved devices
This description comes directly from the study's public registry record.
Namaijah Faison Clinical Research Coordinator · 215-432-5000 · Namaijah.Faison@pennmedicine.upenn.edu
Jessica Nunez Project Manager · 215-829-3712 · Jessica.Nunez@pennmedicine.upenn.edu
Always discuss trial participation with your own doctor first.
| Pennsylvania Hospital, Center for Breast Imaging | Philadelphia, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07067788